Retail Private Market Access: Opportunity or Exit Liquidity?

My neighbor stopped me at the front gate last Saturday. She’d seen an advert. “You can buy OpenAI now,” she said, eyes shining. “For five hundred quid.”

I asked her who was selling.

She paused. Frowned. “What do you mean, who?”

That’s the question, isn’t it? When something’s being sold to you with a tidy bow on top, the first thing you should ask is who’s the seller. Because somebody is. And they’re probably not your friend.

Two new products launched in the past few weeks promising regular folks early access to companies like OpenAI, xAI, Anthropic and SpaceX. No accreditation needed. Small minimums. At first glance it sounds like the financial democracy people have been demanding for decades.

Or does it? Let’s have a proper look.

The Velvet Rope Got Lowered 🎟️

For the first time in decades, the rules around who can invest in private companies have been quietly rewritten.

For most of recent history, the best investments were behind a velvet rope. To get past it, you needed to be an “accredited investor” — meaning rich enough that the regulator assumed you could afford to lose a few quid. Everyone else had to wait until companies went public, which was usually after the biggest gains had already happened.

That rope is now being lowered, in three places at once.

Trump’s August 2025 executive order told the Department of Labor to rewrite the rules so that 401(k) retirement accounts can include private equity, private credit, real estate and crypto. A week later, the SEC scrapped its rule that closed-end funds investing in private companies had to limit themselves to wealthy investors. Europe passed ELTIF 2.0, killing the €10,000 minimum that kept regular people out of long-term private funds. Morningstar counted 189 new ELTIF vehicles authorised in two years.

In crypto, platforms like Hyperliquid, Binance Wallet and Jupiter started offering “tokenised stocks” of companies that aren’t even public yet. Pre-IPO speculation, available on your phone.

So far, so utopian. Why isn’t everyone celebrating?

The Sandwich Theory of Investing 🥪

Here’s the thing nobody tells you about “early access” products: they’re not actually early.

Think about a sandwich. The good bit is in the middle. The crusts are at the ends.

Real early-stage investing is the middle. You bought OpenAI when it was a research lab nobody had heard of. You bought xAI when Elon was tweeting about it from his back garden. The price was peanuts. The risk was enormous. The potential return was 1,000x.

What’s being offered to retail now is the second crust. AngelList’s new USVC fund lets you buy a basket of stakes in xAI, Anthropic, OpenAI and others starting at £500. Robinhood Ventures Fund I just bought $75 million of OpenAI common stock and offers you exposure through a NYSE listing.

Sounds brilliant. Until you do the maths.

The seller on the other side of that trade isn’t the company itself. It’s often a 2017 angel investor or an early employee who bought their stake at one-thousandth of the current price. They’re sitting on a 200x gain. They want out. They want a buyer. You are the buyer.

Your potential upside? OpenAI is being valued at $852 billion in these deals. For you to make 10x on that, OpenAI needs to be worth $8.5 trillion. That’s larger than the entire Chinese stock market. Possible? Sure. Probable? Have a word with yourself.

This isn’t financial democracy. It’s risk transfer dressed up as opportunity. The people who got rich are getting out. The people who hope to get rich are getting in. Guess which side has more information.

The Fee Sleight of Hand 🎩

The marketing says one fee. The fine print says something else entirely.

USVC is publicly marketed as having a 1% management fee with no performance fee. Sounds reasonable. Sounds fair.

Look at the actual filings on their website though. Net annual expenses come in around 2.5%. Gross expense ratio runs about 3.6% once you include the underlying fund fees. That’s nearly four times what was advertised on the front page.

Why does this matter? Compounding works both ways. A 3.6% annual drag over 10 years takes a 100% gross return down to roughly 40% net. The companies in the basket might triple. Your share of that growth gets sliced in half before it reaches your account.

Things you should know before buying any of these new private market products:

• Read the actual prospectus, not the marketing page. The numbers are different.
• Check what valuation you’re buying at versus what early investors paid. If the gap is more than 100x, you’re likely buying the second crust.
• Find out who’s selling. If it’s a 2017 angel cashing out, you’re funding their retirement. If it’s the company raising fresh capital, that’s a different story.
• Tokenised stocks aren’t real stocks. They’re derivatives that track a price. The legal protections aren’t the same.
• Distributions to private equity investors have been in drought for four straight years. The promised returns aren’t arriving even for the professionals.

None of this means these products are scams. They’re entirely legal. Some of them might even make you money. But the marketing language and the mechanical reality are different things, and the gap between them is where you lose your shirt if you’re not paying attention.

What’s Happening In Crypto Right Now 📈

Bitcoin is grinding higher despite macro chaos, and the institutional bid refuses to break.

BTC is trading around $78,300 after clawing back from $76,000. Gold sits at $4,570 per ounce. Brent crude hovers around $108 per barrel as the Iran ceasefire wobbles.

The institutional accumulation has been relentless. Spot Bitcoin ETFs pulled in $471 million on Thursday alone, the highest since late February. BlackRock’s IBIT now holds over 800,000 BTC. Strategy added another $2.54 billion this week and now sits on 818,000 BTC. When the largest buyers in the world keep loading up into weakness, that tells you where smart money sees value.

Funding rates remain deeply negative, meaning shorts are crowded. Historically that creates the conditions for a violent squeeze higher.

The regulatory news is properly bullish. SEC Chair Paul Atkins declared an end to regulation through enforcement. Fed nominee Kevin Warsh backed crypto in his Senate hearing. The CLARITY Act got past its biggest obstacle on Friday, with a compromise on stablecoin yield clearing the way for Senate Banking Committee markup.

Morgan Stanley launched its Bitcoin Trust this week, with $2 trillion in assets under management bringing serious heft. Their prospectus is worth reading though — it explicitly warns that the crypto market is heavily manipulated. The bank that’s now selling Bitcoin to its wealthy clients is also telling them, in writing, that the market they’re buying into is rigged. That’s either refreshing honesty or a very British sort of corporate hedging. Possibly both.

The base case for the coming weeks: BTC grinds higher. Negative funding, strong ETF inflows and continued corporate accumulation point to a market where shorts are offsides. $80,000 remains the key resistance to watch.

Where This Leaves Us

Two things are true at once. The financial system is opening up to ordinary people in ways that haven’t been possible for decades. And the same opening is being used to offload risk from people who got there first onto people who are arriving last.

It’s a bit like being invited to join an exclusive members’ club, only to discover the existing members are all heading for the exit and you’ve been handed the bar tab. The doors are open. Whether that’s a gift or a trap depends entirely on whether you understand what you’re walking into.

My prediction? The next 12 months bring a flood of these “retail-friendly” private market products. Most will perform poorly. The ones that work will be the ones where retail investors did genuine homework instead of swallowing the marketing.